RESULTS OF MULTICENTER STUDY OF PIDOTIMOD FOR THE PROPHYLAXIS OF ACUTE RESPIRATORY INFECTIONS IN FREQUENTLY AILING CHILDREN

The article describes actual pediatric problem — frequent development of respiratory infections in children. Authors present the results of Russian multicenter study of effectiveness and safety of pidotimod (Imunorix) in frequently ailing children. It was shown that treatment with pidotimod during 3...

Full description

Saved in:
Bibliographic Details
Published inVoprosy sovremennoĭ pediatrii Vol. 9; no. 2; pp. 40 - 44
Main Authors L.S. Namazova-Baranova, S.M. Kharit, I.A. Tuzankina, T.N. Kozhevnikova, T.E. Taranushenko, A.A. Alekseeva
Format Journal Article
LanguageEnglish
Published "Paediatrician" Publishers LLC 01.03.2010
Online AccessGet full text

Cover

More Information
Summary:The article describes actual pediatric problem — frequent development of respiratory infections in children. Authors present the results of Russian multicenter study of effectiveness and safety of pidotimod (Imunorix) in frequently ailing children. It was shown that treatment with pidotimod during 30 days resulted in decreased rate of acute respiratory infections and their complications including ones with necessity of antibacterial therapy compared to children from control group. The dynamics of immunological rates in blood serum was studied.Key words: frequently ailing children, acute respiratory infections, prophylaxis, pidotimod.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(2):40-44)
ISSN:1682-5527
1682-5535